Cargando…
Remimazolam besylate versus propofol for deep sedation in critically ill patients: a randomized pilot study
OBJECTIVE: To compare the efficacy and safety of remimazolam besylate and propofol for deep sedation in critically ill patients. METHODS: In this single-center, prospective, randomized, controlled pilot study, patients in the intensive care unit (ICU) requiring deep sedation were randomized to recei...
Autores principales: | Tang, Yun, Gao, Xuehui, Xu, Jiqian, Ren, Lehao, Qi, Hong, Li, Ruiting, Shu, Huaqing, Zou, Xiaojing, Yuan, Shiying, Yang, Xiaobo, Shang, You |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694930/ http://dx.doi.org/10.1186/s13054-023-04760-8 |
Ejemplares similares
-
Remimazolam besylate versus propofol for long-term sedation during invasive mechanical ventilation: a pilot study
por: Tang, Yun, et al.
Publicado: (2022) -
Long-term sedation with remimazolam besylate versus propofol in critically ill patients during invasive mechanical ventilation: a study protocol for a multicenter randomized non-inferior trial
por: Yang, Xiaobo, et al.
Publicado: (2023) -
Remimazolam besylate for sedation of postoperative patients in intensive care units: a phase I, open label, dose-finding study
por: Tang, Yun, et al.
Publicado: (2022) -
The effective doses of remimazolam besylate in the procedural sedation of endoscopic retrograde cholangiopancreatography
por: Tan, Dan‐Dan, et al.
Publicado: (2022) -
Remimazolam besylate for the sedation of postoperative patients undergoing invasive mechanical ventilation in the ICU: a prospective dose‒response study
por: Chen, Xiaoyan, et al.
Publicado: (2022)